and poses a significant threat to vulnerable populations, particularly as we enter peak respiratory virus season,” Stéphane Bancel, CEO of Moderna, said in a news release Monday. “COVID-19 remains a leading cause of death in the U.S. As part of the FDA’s update, the bivalent Moderna and Pfizer/BioNTech Covid-19 vaccines are no longer authorized for use in the United States.Īccording to the FDA, babies and young children ages 6 months through 4 years who have not been vaccinated against the coronavirus are eligible to receive three doses of the updated Pfizer/BioNTech shot or two doses of the updated Moderna booster.įor those in that age group who have been vaccinated, the number and timing of doses depends on the doses they’ve previously received.Īccording to the FDA, people 5 and older are eligible to receive a single dose of the updated vaccines at least two months since their last dose of any Covid-19 shot, regardless of previous vaccination. The updated vaccines are approved for people 12 and older and are authorized under emergency use for individuals 6 months through 11 years old. How to replace your Covid-19 vaccine card and when you still need it There are multiple options for replacing the important document. are eligible to receive this season’s COVID-19 vaccine, even if they have never been vaccinated against COVID-19 before,” Albert Bourla, chairman and chief executive officer at Pfizer, said in a news release.ĭon't fret if you've lost your vaccine card. Now, most people 6 months or older in the U.S. Overall, the new FDA decision “comes at a time when COVID-19 cases are once again climbing. So there is a substantial level of population immunity already.” “Right now we have the vast majority of the population with vaccine immunity, natural immunity, or both. I don’t think we’re going to have a surge at the level that we saw a year or two years ago, but where it will peak I think remains to be seen,” he said. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, who was not involved in developing either the Moderna or Pfizer vaccines but previously helped study the Johnson & Johnson vaccine.įor the approaching fall and winter, “the trajectory of where we’re going is difficult to tell. However, the overall uptick is small relative to recent season peaks.Īs for Covid-19, “at the present time, we are seeing an uptick in infection rates as well as hospitalizations, however, the absolute rates of severe disease, hospitalizations, and death are still very low compared with where we were a year ago and two years ago,” said Dr. RSV cases are also beginning to slightly increase in parts of the West and Midwest, according to the CDC. The CDC has already warned that RSV levels are starting to pick up in the South, doubling between late July and late August. Palmer/CDCĬDC warns that RSV cases may be starting to riseĮxperts have expressed concerns about the impacts the triple threat of viral illnesses will have this fall. RSV is the most common cause of bronchiolitis and pneumonia among infants and children, under 1-year of age. The virion is variable in shape, and size, with an average diameter between 120-300nm. This highly-magnified, 1981 transmission electron microscopic (TEM) image, reveals some of the morphologic traits exhibited by a human respiratory syncytial virus (RSV). We very much encourage those who are eligible to consider getting vaccinated.” “The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness, and manufacturing quality. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release Monday. “Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” Dr. They’re debuting amid a late summer rise in Covid-19 hospitalizations in the United States and growing concerns about the effects that the triple threat of respiratory viruses – coronavirus, flu and respiratory syncytial virus – may have this fall and winter season. Health officials are urging people to get vaccinated as soon as the shots are available. The advisory group is scheduled to meet to discuss Covid-19 vaccines Tuesday, meaning the vaccines could become available within just a few days at certain pharmacies and doctor’s offices. Covid cases are rising, just as new vaccines are almost ready
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |